Page last updated: 2024-08-17

levodopa and Angelman Syndrome

levodopa has been researched along with Angelman Syndrome in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	3 (60.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Danilchenko, V; Dhar, A; Matiashova, L; Miranda, AV; Papakosta, V; Tsagkaris, C; Zacharopoulou, L	1
Bacino, CA; Barbieri-Welge, RL; Barnes, GN; Bird, LM; Chu, HC; Erickson, CA; Fu, C; Haas, KF; Horowitz, LT; Hundley, RJ; Jeremy, R; Kothare, SV; Nespeca, MP; Noll, LM; Olson, HE; Poduri, A; Rotenberg, A; Rufo, PA; Sadhwani, A; Skinner, SA; Slavotinek, A; Tan, WH; Weeber, EJ; Willen, JM; Wink, LK	1
du Mee, D; Elgersma, Y; Kingma, J; Santos, SS; Sonzogni, M; van Woerden, GM; Wallaard, I	1
Bird, LM; Tan, WH	1
Harbord, M	1

Reviews

2 review(s) available for levodopa and Angelman Syndrome

Article	Year
Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors. Current gene therapy, 2020, Volume: 19, Issue:6 Topics: Angelman Syndrome; Animals; Anti-Anxiety Agents; Antiparkinson Agents; Buspirone; Diet, Ketogenic; Dietary Supplements; Disease Models, Animal; Gene Silencing; Genetic Therapy; Humans; Levodopa; Mice; Minocycline; Neurons; Signal Transduction; Topoisomerase I Inhibitors; Ubiquitin-Protein Ligases	2020
Pharmacological therapies for Angelman syndrome. Wiener medizinische Wochenschrift (1946), 2017, Volume: 167, Issue:9-10 Topics: Angelman Syndrome; Animals; Clinical Trials as Topic; Disease Models, Animal; Gene Silencing; Levodopa; Mice; Minocycline; Oligoribonucleotides, Antisense; Seizures; Sleep Wake Disorders; Topoisomerase Inhibitors; Ubiquitin-Protein Ligases	2017

Article

Year

Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors.

Current gene therapy, 2020, Volume: 19, Issue:6

Topics: Angelman Syndrome; Animals; Anti-Anxiety Agents; Antiparkinson Agents; Buspirone; Diet, Ketogenic; Dietary Supplements; Disease Models, Animal; Gene Silencing; Genetic Therapy; Humans; Levodopa; Mice; Minocycline; Neurons; Signal Transduction; Topoisomerase I Inhibitors; Ubiquitin-Protein Ligases

2020

Pharmacological therapies for Angelman syndrome.

Wiener medizinische Wochenschrift (1946), 2017, Volume: 167, Issue:9-10

Topics: Angelman Syndrome; Animals; Clinical Trials as Topic; Disease Models, Animal; Gene Silencing; Levodopa; Mice; Minocycline; Oligoribonucleotides, Antisense; Seizures; Sleep Wake Disorders; Topoisomerase Inhibitors; Ubiquitin-Protein Ligases

2017

Trials

1 trial(s) available for levodopa and Angelman Syndrome

Article	Year
A randomized controlled trial of levodopa in patients with Angelman syndrome. American journal of medical genetics. Part A, 2018, Volume: 176, Issue:5 Topics: Angelman Syndrome; Animals; Biomarkers; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Humans; Levodopa; Long-Term Potentiation; Mice; Neuropsychological Tests; Treatment Outcome	2018

Other Studies

2 other study(ies) available for levodopa and Angelman Syndrome

Article	Year
A behavioral test battery for mouse models of Angelman syndrome: a powerful tool for testing drugs and novel Molecular autism, 2018, Volume: 9 Topics: Angelman Syndrome; Animals; Behavior Rating Scale; Behavior, Animal; Disease Models, Animal; Female; Levodopa; Male; Mice, Mutant Strains; Minocycline; Mutation; Phenotype; Ubiquitin-Protein Ligases	2018
Levodopa responsive Parkinsonism in adults with Angelman Syndrome. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2001, Volume: 8, Issue:5 Topics: Adult; Angelman Syndrome; Antiparkinson Agents; Female; Humans; Levodopa; Male; Parkinsonian Disorders	2001